focus -WSS

focus

author：knowledge 2025-08-24 23:09:52 - browse：933

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： UnitedHealth financials solid despite Change Healthcare cyberattack

focus

WSS

Why health care costs have stayed mostly flat since 2010

Close Medicare's dangerous gaps in addiction treatment coverage

Why health records don't always know when patients are dead

Medicare drug price negotiation hasn't dried up venture capital

CRISPR gene editing developments we’re watching in 2024

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

hotspot

focus

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Dogs on Prozac: What pet anti

ChatGPT in medicine: STAT answers readers' burning questions

Violet CEO on training clinicians to promote more inclusive care

Moonlake's readout produced a cash windfall. Risks remain

After traumatic brain injury, life support decisions can use more time

In Memoriam: Notable people who died in 2023

Violet CEO on training clinicians to promote more inclusive care

Drug repurposing or repositioning? The language matters

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Wikipedia

Cell therapy fails to slow type 1 diabetes, but safety is established

Why health care costs have stayed mostly flat since 2010

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Grail spinoff by Illumina should end disastrous merger attempt

More tobacco lobbyists active in statehouses

Medical bills so high, Medicare adding extra digits to claim forms

Wikipedia

focus

focus

leisure time